Factors associated with the risk of adenoma recurrence in distal and proximal colon

Digestion

Volumn 87, Issue 3, 2013, Pages 141-146

  Laiyemo, Adeyinka O ^a,b   Doubeni, Chyke ^d   Pinsky, Paul F ^b   Doria Rose, V Paul ^c   Marcus, Pamela M ^c   Schoen, Robert E ^e   Lanza, Elaine ^b   Cross, Amanda J ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenomatous polyps; Advanced adenoma; Colonoscopy; Distal adenoma; Proximal adenoma

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGE; AGED; ANATOMICAL VARIATION; ARTICLE; BODY MASS; CLINICAL EVALUATION; COLON ADENOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTAL COLON ADENOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); NEOPLASMS SUBDIVIDED BY ANATOMICAL SITE; PRIORITY JOURNAL; PROXIMAL COLON ADENOMA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY ANALYSIS; SEX RATIO; SMOKING; TUMOR RECURRENCE;

EID: 84875659433     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000346281     Document Type: Article

References (25)

1. Doubeni C, Laiyemo AO, Reed G, et al: Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees 2000-2005. Cancer Epidemiol Biomarkers Prev 2009; 18: 2170-2175.
2. Subramanian S, Amonkar MM, Hunt TL: Use of colonoscopy for colorectal cancer screening: evidence from the 2000 National Health Interview Survey. Cancer Epidemiol Biomarkers Prev 2005; 14: 409-416.
3. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN: Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 2006; 295: 2366-2373.
4. Lakoff J, Paszat LF, Saskin R, Rabeneck L: Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 2008; 6: 1117-1121.
5. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L: Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009; 150: 1-8.
6. Singh H, Nugent Z, Demers AA, Kliewer EV, Mahmud SM, Bernstein CN: The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010; 139: 1128-1137.
7. Brenner H, Chang-Claude J, Seiler CM, Rickert A, Hoffmeister M: Protection from colorectal cancer after colonoscopy: a populationbased, case-control study. Ann Intern Med 2011; 154: 22-30.
8. Rex DK, Eid E: Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention. Clin Gastroenterol Hepatol 2008; 6: 506-514.
9. Deng G, Kakar S, Tanaka H, et al: Proximal and distal colorectal cancers show distinct gene-specific methylation profiles and clinical and molecular characteristics. Eur J Cancer 2008; 44: 1290-1301.
10. Ferracin M, Gafà R, Miotto E, et al: The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile. J Pathol 2008; 214: 594-602.
11. Schatzkin A, Lanza E, Freedman LS, et al: The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev 1996; 5: 375-383.
12. Lanza E, Schatzkin A, Ballard-Barbash R, et al: The polyp prevention trial II: dietary intervention program and participant baseline dietary characteristics. Cancer Epidemiol Biomarkers Prev 1996; 5: 385-392.
13. Erratum in: Cancer Epidemiol Biomarkers Prev 1996; 5: 584.
14. Schatzkin A, Lanza E, Corle D, et al: Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med 2000; 342: 1149-1155.
15. Laiyemo AO, Murphy G, Albert PS, et al: Postpolypectomy surveillance guidelines: pre dictive accuracy for advanced adenoma at 4 years. Ann Intern Med 2008; 148: 419-426.
16. Laiyemo AO, Doubeni C, Sanderson AK, et al: Likelihood of missed and recurrent adenomas in the proximal versus the distal colon. Gastrointest Endosc 2011; 74: 253-261.
17. Jacobs ET, Ahnen DJ, Ashbeck EL, et al: Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009; 169: 657-666.
18. Nelson RL, Dollear T, Freels S, Persky V: The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997; 80: 193-197.
19. Gonzalez EC, Roetzheim RG, Ferrante JM, Campbell R: Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 2001; 44: 251-258.
20. Baron JA, Sandler RS, Bresalier RS, et al: A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006; 131: 1674-1682.
21. Bertagnolli MM, Eagle CJ, Zauber AG, et al: Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006; 355: 873-884.
22. Arber N, Eagle CJ, Spicak J, et al: Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355: 885-895.
23. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS: Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 2005; 294: 914-923.
24. Smalley W, Ray WA, Daugherty J, Griffin MR: Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 1999; 159: 161-166.
25. Rostom A, Dubé C, Lewin G, et al: Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the US. Preventive Services Task Force. Ann Intern Med 2007; 146: 376-389.